Ipamorelin: An Overview of the Research

Ipamorelin is widely studied for its selectivity within growth-hormone-axis research. This guide covers what it is, its mechanism as a selective secretagogue, and how it compares with earlier compounds in its class.

What Is Ipamorelin?

Ipamorelin is a synthetic peptide classed as a growth-hormone secretagogue. Its defining research characteristic is selectivity: it is described as binding the ghrelin / growth-hormone-secretagogue receptor with comparatively little effect on cortisol and prolactin pathways relative to earlier secretagogues such as GHRP-2 and GHRP-6.

How Does Ipamorelin Work?

Ipamorelin is studied for its action at the ghrelin receptor, prompting growth-hormone release through that pathway. Because it engages the ghrelin side of the axis, it is commonly studied alongside GHRH analogues such as CJC-1295, which act on the GHRH side.

Ipamorelin vs GHRP-2 and GHRP-6

The earlier secretagogues GHRP-2 and GHRP-6 act on the same receptor but are described as less selective. Ipamorelin's selectivity is the main reason it remains a frequent subject of research and a common comparison point.

Forms, Purity and Handling

• Format: lyophilised powder.

• Purity: greater than or equal to 99% by HPLC.

• COA: per batch.

• Storage: frozen for long-term stability; refrigerated once in solution.

Frequently Asked Questions

What is Ipamorelin?

A synthetic growth-hormone secretagogue studied for its selectivity at the ghrelin receptor.

How is Ipamorelin different from GHRP-2 and GHRP-6?

It is described as more selective, with comparatively little effect on cortisol and prolactin pathways.

What purity should Ipamorelin be?

Greater than or equal to 99% by HPLC with a per-batch COA.

These products are supplied strictly for laboratory and research use only. Not for human or animal consumption.